ExoCellular Diagnostics

Our Story

Shaping the Future of Liquid Biopsy-Based Cancer Detection and Monitoring

About Us

About ExoCellular Diagnostics Inc.

ExoCellular Diagnostics Inc., is a privately held company commercializing liquid biopsy-based cancer diagnostic tests. The Company is headquartered in Cambridge, Massachusetts, USA, and has facilities in Munich, Germany. We  focus on the development and commercialization of novel liquid biopsy-based tests for cancer detection and disease monitoring.


Hsp70-based liquid biopsy for cancer detection and monitoring


Innovative approach for isolating circulating tumor cells

Get Started with ExoCellular Diagnostics

Join us in transforming the world of cancer diagnostics. Contact us today to learn more about our innovative liquid biopsy tests.